We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOD icon
1251
Kodiak Sciences
KOD
$2.5B
$1K ﹤0.01%
151
LXRX icon
1252
Lexicon Pharmaceuticals
LXRX
$1.03B
$1K ﹤0.01%
434
MGNX icon
1253
MacroGenics
MGNX
$233M
$1K ﹤0.01%
209
MGTX icon
1254
MeiraGTx Holdings
MGTX
$1.08B
$1K ﹤0.01%
130
NAUT icon
1255
Nautilus Biotechnolgy
NAUT
$132M
$1K ﹤0.01%
362
NKTR icon
1256
Nektar Therapeutics
NKTR
$2.39B
$1K ﹤0.01%
36
NKTX icon
1257
Nkarta
NKTX
$152M
$1K ﹤0.01%
180
OCUL icon
1258
Ocular Therapeutix
OCUL
$1.83B
$1K ﹤0.01%
262
OPTN
1259
DELISTED
OptiNose
OPTN
$1K ﹤0.01%
21
PAHC icon
1260
Phibro Animal Health
PAHC
$1.5B
$1K ﹤0.01%
38
PEPG icon
1261
PepGen
PEPG
$118M
$1K ﹤0.01%
+95
New +$1.23K
PGEN icon
1262
Precigen
PGEN
$1.94B
$1K ﹤0.01%
708
PMVP icon
1263
PMV Pharmaceuticals
PMVP
$57.1M
$1K ﹤0.01%
132
PRLD icon
1264
Prelude Therapeutics
PRLD
$375M
$1K ﹤0.01%
104
QSI icon
1265
Quantum-Si Incorporated
QSI
$153M
$1K ﹤0.01%
343
STOK icon
1266
Stoke Therapeutics
STOK
$1.84B
$1K ﹤0.01%
126
STRO icon
1267
Sutro Biopharma
STRO
$386M
$1K ﹤0.01%
16
TSVT
1268
DELISTED
2seventy bio
TSVT
$1K ﹤0.01%
+152
New +$2.14K
VNDA icon
1269
Vanda Pharmaceuticals
VNDA
$304M
$1K ﹤0.01%
191
XERS icon
1270
Xeris Biopharma Holdings
XERS
$1.45B
$1K ﹤0.01%
404
LENZ
1271
LENZ Therapeutics
LENZ
$179M
$1K ﹤0.01%
24
OMGA
1272
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1K ﹤0.01%
139
PETQ
1273
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$1K ﹤0.01%
99
GRTS
1274
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1K ﹤0.01%
198
EGRX
1275
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30

Similar funds

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.